A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer.
Cancer Discov
; 1(6): 508-23, 2011 Nov.
Article
in En
| MEDLINE
| ID: mdl-22586653
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Colorectal Neoplasms
/
Receptor, ErbB-2
/
Xenograft Model Antitumor Assays
/
Antibodies, Monoclonal
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Aged80
/
Animals
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Cancer Discov
Year:
2011
Document type:
Article
Affiliation country:
Italy
Country of publication:
United States